|
- Mobile connectivity and diabetes eHealth - "Actionable" SMBG for patients using insulin |
|
Emerging data about ARNT and other transcription factors in gene expression and islet dysfunction in type 2 diabetes and gestational diabetes |
David Kerr, MD, FRCPE Director of Research and Innovation William Sansum Diabetes Center |
Jenny Gunton Chair of Medicine, University of Sydney, Westmead Hospital President, Australian Diabetes Society |
|
- The usefulness of glucose and lipid control in nephropathy and retinopathy - Using HbA1c to diagnose diabetes is neither helpful, nor is it accurate |
|
An Asian diabetes phenotype, or a phenotype in transition?
Juliana Chan Chair Professor, Department of Medicine and Therapeutics Director, Hong Kong Institute of Diabetes and Obesity Co-director, IDF Centre of Education, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong |
Jonathan Shaw Associate Director Health Services of Baker IDI Heart and Diabetes Institute |
|
- The evolving paradigm in T2DM treatment with contemporary and complimentary therapeutic strategies - DPP4 inhibitors: the CV outcomes trials |
|
National diabetes care models: perspective from ASEAN countries |
Lawrence A. Leiter, MD, FRCPC, FACP, FAHA Professor of Medicine and Nutritional Sciences, University of Toronto |
Pongamorn Bunnag Assistant Professor Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University |
|
Type 1 diabetes mellitus in preschool children
Ragnar Hanas, MD, PhD Associate Professor The Sahlgrenska Academy University of Gothenburg Institute of Clinical Sciences |
|
- Optimising glycemic control to protect renal and cardiovascular complications of type 2 diabetes- Findings from ADVANCE-ON - National diabetes care models: perspective from ASEAN countries |
Siew Pheng Chan, MBBS (Malaya), FRCP (Edinburgh), AM (Malaya) Visiting Professor Senior Consultant Endocrinologist Endocrine Unit, Department of Medicine University of Malaya Medical Centre, Kuala Lumpur, Malaysia |
|
- Ethnic differences in genome-wide association studies - Is diabetes truly still a coronary artery disease equivalent? |
|
- The epigenome and its role in diabetes - Adipose tissue inflammation and B regulatory cell dysfunction |
Tai E Shyong Senior consultant, National University Hospital Associate Professor, Yong Loo Lin School of Medicine and Saw Swee Hock School of Public Health, National University of Singapore Associate Professor, Duke-National University of Singapore Graduate Medical School |
Takashi Kadowaki, MD, PhD Professor of Diabetes and Metabolic Diseases University of Tokyo |
|
- Epidemic obesity and the rise of type 2 diabetes in Asia - DPP-4 Inhibitors: Have We Optimized Their Role in the Treatment of Patients With Type 2 Diabetes? |
|
Adiponectin, FGF21 and metabolic homeostasis |
Yoon Kun-Ho Professor of Department of Endocrinology and Metabolism, Seoul St. Mary’s Hospital, The Catholic University of Korea |
Xu Aimin, PhD, MD Professor of Medicine, Director of State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong |